IgE, Allergic Diseases, and Omalizumab
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3929-3944
Author(s):
L. M. DuBuske
Drug Targeting in Bronchial Asthma: Inhaled Corticosteroids Should Reach the Peripheral Airways
Journal:
Current Drug Therapy
Volume:
1
Page:
257-261
Author(s):
P.N.R. Dekhuijzen
Editorial [Guest Editor: Strategies for the Improvement of Asthma Therapy (Executive Editor: Andreas Pahl)]
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3173-3174
Author(s):
Andreas Pahl
Current Animal Models of Bronchial Asthma
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3175-3194
Author(s):
I. Kurucz and I. Szelenyi
Pharmacogenomics of Asthma
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3195-3206
Author(s):
Andreas Pahl, Ewald Benediktus and Ligia Chialda
Phosphodiesterase 7A: A New Therapeutic Target for Alleviating Chronic Inflammation?
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3207-3220
Author(s):
M. A. Giembycz and S. J. Smith
Nitric Oxide in Asthma Therapy
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3221-3232
Author(s):
Gert Folkerts and Frans P. Nijkamp
Biopharmaceutical Therapeutics for Asthma Remodeling
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3233-3240
Author(s):
A. M. Das, D. E. Griswold, T. J. Torphy and L. Li
Corticosteroid Design for the Treatment of Asthma: Structural Insights and the Therapeutic Potential of Soft Corticosteroids
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3241-3260
Author(s):
Nicholas Bodor and Peter Buchwald
Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists.
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3261-3279
Author(s):
A. Miller-Larsson and O. Selroos